At GSK, we want to supercharge our data capability to better understand our patients and accelerate our ability to discover vaccines and medicines. The Onyx Research Data Platform organization represents a major investment by GSK R&D and Di...
At GSK, we unite science, technology and talent to get ahead of disease together. Our ambition is to positively impact the health of 2.5 billion people over the next decade. We are building a future where state-of-the-art software, AI, and ...
The Onyx Research Data Tech organization is GSK’s Research data ecosystem which has the capability to bring together, analyze, and power the exploration of data at scale. We partner with scientists across GSK to define and understand their ...
Business Introduction: GSK remains committed to achieving bold commercial ambitions for the future. By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance momentum to significantly increase our p...
Understanding the dynamics of healthcare professionals and brand positioning is critical to the success of our marketing strategies. The way we build and maintain strong relationships with key healthcare professionals and stakeholders has b...
We make and supply medicines and vaccines all around the globe and our teams own every production stage, from creating quality products at our manufacturing sites to designing effective supply forecasting and regulatory inspections;all pow...
Business Introduction: GSK remains committed to achieving bold commercial ambitions for the future. By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance momentum to significantly increase our p...
Territory to include, but not limited to: Augusta/Savannah, GA Role Overview: For more than 140 years, GSK has pioneered novel research methods and technologies to help protect people from infectious diseases. Our vaccines portfolio of ...
We manufacture and supply reliable, high-quality medicines and vaccines to meet patients’ needs and drive our performance. Our network of 37 medicines and vaccines manufacturing sites delivered 1.7 billion packs of medicines and 409 milli...
Cancer is unrelenting, but so are we. We strive to outpace cancer, improve patient outcomes, and enhance access to innovative therapies through leading science and technology via our talented people and strong partnerships. Our ambition is ...